The retail sector has certainly provided the stock market with its fair share of ups and downs. As fickle as the consumer is, we have seen some names take off over the past few months while others have been saddled with weaker margins, little guidance, complaints about a stronger dollar, and just plain lousy inventory.…
Details
Today we stepped back a bit and looked at the charts to assess the damage done in this latest barrage of selling. Tuesday was vicious. From the outset, there was no room to bid in this market – the rough news from Europe and Asia really hammered any opportunities into oblivion. Furthermore, yesterday’s bounce was…
DetailsUnderstanding technical analysis is an art form that is shaped by experience – and it is critical for trading options. As a charting veteran, I have evaluated thousands of charts, a daily ritual that typically includes 100 charts in a single day. That may seem exhausting, but it is required if I want to perfect…
DetailsDuring today’s webinar, the name of the game was options trading risk management. As any seasoned trader or investor will tell you, it’s tough to sell when you have a winner, but it is paramount to have a strategy in place. If you don’t, that winner can quickly turn into a loser, and your days…
DetailsMedivation (MDVN) is part of a white hot biotech group that has been leading the markets to all time highs. We have seen “first tier” names such as Gilead, Celgene, Regeneron, Biogen-Idec and Amgen showing great leadership, which brings others along with it (“A rising tide lifts all boats!”). Medivation is a biopharmaceutical company specializing…
DetailsI often hear analysts and talking heads discuss reasons for the stock market’s movements. Their conclusions are really just a collection of their emotions packaged together to form a result. I have to ignore their commentary, because if I listen too carefully, I may get swept up trying to rationalize the action. We all know…
Details
During today’s webinar, I spent quite a bit of time talking about the recent market developments and market structure. Because sentiment is starting to get a bit overbought and heated, everyone is asking, “Is a market pullback coming?” The answer, of course, is, “Maybe.” A pullback certainly would not be surprising given its current condition.…
DetailsGreen Mountain Coffee Roasters (GMCR) is the company that produces those little K cups and the Keurig machines that produce the one-cup-at-a-time wonder. As an alternative to Starbucks and other coffee houses, the K cups are a great change from the traditional pot of coffee. However, the company has not been short of controversy. Often…
DetailsCempra (CEMP) specializes in treating critical bacterial infectious diseases. It has a number of Phase 3 clinical candidates specifically targeted at drug-resistant bacterial infections in the hospital and the community. Their work could not come at a better time. As widespread use of general antibiotics continues, we are seeing an increase of “super-germs” or infections…
Details
Today was a very special webinar with RBC’s internet analyst Mark Mahaney, a brilliant strategist who leads the group that follows some of the biggest names out there. Mark was gracious enough to spend a good 45 minutes with us talking about some of names he covers, and he talked extensively about opportunities in Amazon…
Details
